Steven Porter, chairman and chief executive officer of Ceragenix, said: We’re very pleased to announce this progress in our licensing efforts. We are very encouraged by the performance of the CeraShield antimicrobial coating in comparison to an established antimicrobial device in a rigorous in-vitro testing methodology undertaken by the partner leading to this announcement.
